• Beef Cattle Research Council on Facebook
  • Beef Cattle Research Council on Twitter
  • Beef Cattle Research Council on Youtube

Looking for foragebeef.ca? Click here for more info

Understanding Mycoplasma bovis

Project Code: ANH.30.17
Completed: In Progress. Results expected in March 2022.

Project Title:

Investigating antimicrobial resistance (AMR) and virulence factors of Mycoplasma bovis


Murray Jelinski D.V.M. murray.jelinski@usask.ca

Murray Jelinski D.V.M. (Western College of Veterinary Medicine); Tim McAllister Ph.D. and Trevor Alexander Ph.D. (Agriculture Agri-Food Canada Lethbridge); Scott Weese D.V.M.(University of Guelph)


Mycoplasma bovis(M. bovis) is associated with respiratory disease, arthritis, mastitis and ear infections in cattle. It’s not clear whether the same strains of M. bovis are responsible for each of these different manifestations. Developing a vaccine against M. bovis is difficult because it can switch which antigens it expresses on the cell surface. M. bovismay also becoming more antimicrobial resistant and may be able to transfer its antimicrobial resistance genes to other respiratory disease pathogens.


To gain a better understanding of M. Bovis and how it manifests itself in different diseases. 

What They Will Do:

The research team will sequence the microbial genomes and characterize the upper and lower respiratory microbiomes (including all Mycoplasma species) of 50 cattle dying from mycoplasma pneumonia to those of 50 cattle dying from other respiratory diseases. They will examine which Mycoplasma species are present in the upper vs. lower respiratory tract as well as differences between calves infected with mycoplasma vs. other forms of pneumonia.

Whole genome sequencing and phenotypic antimicrobial resistance testing will be conducted on 250 M. bovis isolates from 2008 through 2019 to assess how antimicrobial resistance profiles have changed over time. These samples will also be used to determine whether different Mycoplasma strains prefer the lung or the joints.

Since the expression of the surface proteins is so variable, the researchers will use the whole genome sequence data to look for other known virulence factors. These results will be compared to cell culture virulence assays as well as for differences in adhesion to bovine bronchial and nasal cells.

Conjugation assays will be conducted to determine whether M. bovis can exchange antimicrobial resistance genes with other bacteria such as M. haemolytica, H. somni, and P. multocida.


This project will quantify changes in antimicrobial resistance patterns over time and evaluate whether M. bovis exchanges antimicrobial resistance genes with other bovine respiratory disease pathogens. This research will also support the development of more effective treatment regimens, as well as identify more promising vaccine candidates.

View Fact Sheet PDF

Proudly Funded By:

© 2020 BCRC. All Rights Reserved  |  Council Login

Privacy Policy | Terms of Service | Sitemap | info [at] beefresearch [dot] ca | Site By Media Dog